<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Andrijauskaite K</submitter><funding>NCI NIH HHS</funding><pagination>360-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4807400</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(7)</volume><pubmed_abstract>The ability to genetically modify T cells is a critical component to many immunotherapeutic strategies and research studies. However, the success of these approaches is often limited by transduction efficiency. As retroviral vectors require cell division for integration, transduction efficiency is dependent on the appropriate activation and culture conditions for T cells. Naive CD8(+) T cells, which are quiescent, must be first activated to induce cell division to allow genetic modification. To optimize this process, we activated mouse T cells with a panel of different cytokines, including interleukin-2 (IL-2), IL-4, IL-6, IL-7, IL-12, IL-15 and IL-23, known to act on T cells. After activation, cytokines were removed, and activated T cells were retrovirally transduced. We found that IL-12 </pubmed_abstract><journal>Cancer gene therapy</journal><pubmed_title>IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells.</pubmed_title><pmcid>PMC4807400</pmcid><funding_grant_id>P30 CA138313</funding_grant_id><funding_grant_id>P30CA138313</funding_grant_id><funding_grant_id>P01 CA154778</funding_grant_id><funding_grant_id>P01CA54778-01</funding_grant_id><pubmed_authors>Cole DJ</pubmed_authors><pubmed_authors>Suriano S</pubmed_authors><pubmed_authors>Kochenderfer JN</pubmed_authors><pubmed_authors>Moxley KM</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Mehrotra S</pubmed_authors><pubmed_authors>Cloud CA</pubmed_authors><pubmed_authors>Salem ML</pubmed_authors><pubmed_authors>Kesarwani P</pubmed_authors><pubmed_authors>Paulos CM</pubmed_authors><pubmed_authors>Andrijauskaite K</pubmed_authors><pubmed_authors>Rubinstein MP</pubmed_authors><pubmed_authors>Stefanik LS</pubmed_authors><pubmed_authors>Garrett-Mayer E</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells.</name><description>The ability to genetically modify T cells is a critical component to many immunotherapeutic strategies and research studies. However, the success of these approaches is often limited by transduction efficiency. As retroviral vectors require cell division for integration, transduction efficiency is dependent on the appropriate activation and culture conditions for T cells. Naive CD8(+) T cells, which are quiescent, must be first activated to induce cell division to allow genetic modification. To optimize this process, we activated mouse T cells with a panel of different cytokines, including interleukin-2 (IL-2), IL-4, IL-6, IL-7, IL-12, IL-15 and IL-23, known to act on T cells. After activation, cytokines were removed, and activated T cells were retrovirally transduced. We found that IL-12 </description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul</publication><modification>2025-04-19T01:25:27.476Z</modification><creation>2019-03-27T03:10:16Z</creation></dates><accession>S-EPMC4807400</accession><cross_references><pubmed>26182912</pubmed><doi>10.1038/cgt.2015.28</doi></cross_references></HashMap>